0503 Share Price

Open 1.81 Change Price %
High 1.86 1 Day 0.03 1.66
Low 1.81 1 Week 0.00 0.00
Close 1.84 1 Month 0.03 1.66
Volume 1057000 1 Year 0.01 0.55
52 Week High 2.19
52 Week Low 1.64
0503 Important Levels
Resistance 2 1.89
Resistance 1 1.87
Pivot 1.84
Support 1 1.81
Support 2 1.79
HKG HongKong Most Active Stocks
3800 0.82 7.89%
0566 3.91 0.00%
8299 0.02 0.00%
0364 0.02 0.00%
0061 0.03 0.00%
0939 6.17 0.98%
1398 5.25 0.96%
0648 0.04 0.00%
3988 3.85 1.05%
0559 0.18 0.00%
More..
HKG HongKong Top Gainers Stocks
1062 0.37 42.31%
8202 0.85 34.92%
0988 0.38 26.67%
8155 0.06 20.00%
3918 4.02 17.89%
8176 8.79 14.90%
0475 1.27 12.39%
0351 0.20 11.11%
0125 3.23 10.24%
0672 1.30 10.17%
More..
HKG HongKong Top Losers Stocks
4335 100.00 -20.00%
0515 0.30 -16.67%
8002 4.00 -15.97%
8026 0.24 -14.29%
1182 0.19 -13.64%
0379 0.07 -12.50%
8165 0.08 -11.11%
8217 9.98 -10.89%
0479 0.09 -10.00%
0399 0.45 -10.00%
More..

Lansen Pharmaceutical (HKG: 0503)

0503 Technical Analysis 3
As on 26th Jun 2017 0503 Share Price closed @ 1.84 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.80 & Buy for SHORT-TERM with Stoploss of 1.81 we also expect STOCK to react on Following IMPORTANT LEVELS.
0503 Target for June
1st Target up-side 1.84
2nd Target up-side 1.89
3rd Target up-side 1.94
1st Target down-side 1.7
2nd Target down-side 1.65
3rd Target down-side 1.6
0503 Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drugs - Generic
Offical website http://www.lansen.com.cn
0503 Address
0503
Building 14
Room 109
Ningbo, 315100
China
Phone: 86 574 8309 9777
Fax: 86 574 8309 9700
0503 Latest News
Result of AGM   London South East (registration) (blog)   - 21st Jun 17
Cathay's Lansen Arm Recovers 60% Of Flood Losses From Insurance Cover   London South East (registration) (blog)   - 20th Jun 17
Settlement of insurance claims received by Lansen   London South East (registration) (blog)   - 20th Jun 17
Cathay International To Net USD4.0 Million From Subsidiary Dividend   London South East (registration) (blog)   - 19th Jun 17
Lansen's declaration & payment of special dividend   London South East (registration) (blog)   - 19th Jun 17
Unusual Activity Spotted in Lansen Pharmaceutical Holdings Ltd (0503.HK)   Union Trade Journal   - 13th Jun 17
Lansen's proposal to approve a special dividend   London South East (registration) (blog)   - 07th Jun 17
Lansen Pharmaceutical appoints Wu Zhen Tao as chairman   Reuters Key Development   - 30th Mar 17
Lansen Pharmaceutical updates on disposal of Starry shares   Reuters Key Development   - 15th Mar 17
China Markets Live - Shanghai reels from last-hour selling to end lower ...   South China Morning Post (subscription)   - 07th Sep 15
Interactive Technical Analysis Chart Lansen Pharmaceutical ( 0503 HKG HongKong )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Lansen Pharmaceutical
0503 Business Profile
Lansen Pharmaceutical Holdings Limited, an investment holding company, develops, produces, and sells specialty prescription western pharmaceuticals for the treatment of rheumatic diseases in the People’s Republic of China and internationally. It operates in Specialty Pharmaceuticals, Plant Extract and Healthcare Products, and Other Pharmaceuticals segments. The company’s core rheumatic specialty prescription western pharmaceuticals comprise Pafulin, which includes total glucosides of white peony capsules; Tuoshu, a leflunomide tablet; and MMF. It also offers other pharmaceuticals that include Bazhen Keli, a gynecological product; Yinxingye Pian, Paracetamol orally disintegrating tablets, and Dingpeng Rugao; and Huperzine A capsules, Chanfukang Keli, Ganda Pian, Xinnaojian Jiaonang, Runing Pian, Jian'er Qingjie Ye, and Xiao'er Jianwei Tangjiang, as well as Chinese medicine extracts and healthcare products. In addition, the company distributes human-like collagen dressing products, which are used for the suppression and mitigation of skin inflammation responses caused by various reasons, such as dermatitis, sensitive skin, acne, and laser therapy under the Kefumei brand in China. The company was founded in 2001 and is headquartered in Ningbo, the People’s Republic of China. Lansen Pharmaceutical Holdings Limited is a subsidiary of Cathay International Holdings Limited.